NON-INVASIVE BLOOD GLUCOSE CONCENTRATION SENSING USING LIGHT MODULATION

• US 20150141763A1
• Filed: 03/12/2014
• Published: 05/21/2015
• Est. Priority Date: 11/18/2013
• Status: Abandoned Application

• Current Assignee: Honeywell International Inc.
• Original Assignee: Honeywell International Inc.
• Inventors: Roth, Hans, Mathan, Santosh
• Application Number:
  US14/206,520
• Publication Number:
  US 20150141763A1
• Time in Patent Office: Days
• US Class Current: 600/301
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: A61B 5/378 Visual stimuli
• CPC Class Codes: A61B 5/398 Electrooculography [EOG], e.g. detecting nystagmus; Electroretinography [ERG]
• CPC Class Codes: A61B 5/6821 Eye

Abstract

A non-invasive blood glucose concentration sensing system and method includes emitting light of a first color into an eye of the user and then emitting light of a second color into the eye of the user, or flashing blue light into the eye of the user. Neurophysiological brain activity and electrical responses of the eye of the user are sensed during and after emitting or flashing of the light into the eye of the user. In a processor, one or both of the sensed neurophysiological brain activity and the sensed electrical responses of the eye are correlated to the glucose concentration in the blood of the user.

Claims

1. A method for determining glucose concentration in the blood of a user, the method comprising the steps of:

emitting light of a first color into an eye of the user;

emitting light of a second color into the eye of the user;

sensing neurophysiological brain activity and electrical responses of the eye of the user during and after emitting the light of the first and second colors into the eye of the user; and

in a processor, correlating one or both of the sensed neurophysiological brain activity and the sensed electrical responses of the eye to the glucose concentration in the blood of the user.

2. The method of claim 1, wherein:

the step of emitting light of a first color comprises varying intensity of the light of the first color for a predetermined time period to attain a predetermined maximum intensity; and

the step of emitting light of a second color comprises varying intensity of the light of the second color for the predetermined time period to attain the predetermined maximum intensity.

3. The method of claim 2, further comprising:

using a camera to take an image of the eye of the user;

evaluating the image, in the processor, to determine retinal health of the eye; and

determining the predetermined time period and the predetermined maximum intensity based on the retinal health.

4. The method of claim 1, wherein:

the step of emitting light of a first color comprises emitting a pulse of light of the first color at a predetermined intensity and for a predetermined time period; and

the step of emitting light of a second color comprises emitting a pulse of light of the second color at the predetermined intensity and for the predetermined time period

5. The method of claim 4, further comprising:

using a camera to take an image of the eye of the user;

evaluating the image, in the processor, to determine retinal health of the eye; and

determining the predetermined time period and the predetermined intensity based on the retinal health.

6. The method of claim 1, wherein the first and second colors are opponent colors.

7. The method of claim 1, further comprising:

controlling the light of the first and second colors to limit retinal pigment bleaching in the eye of the user to a predetermined maximum bleaching percentage.

8. The method of claim 7, wherein the predetermined maximum bleaching percentage is ≦

20%.

9. The method of claim 1, wherein:

the light of the first color corresponds with long-preferring photoreceptor cones; and

the light of the second color corresponds with middle-preferring photoreceptor cones.

10. The method of claim 1, wherein:

the light of the first color corresponds with long-preferring photoreceptor rods; and

the light of the second color corresponds with middle-preferring photoreceptor rods.

11. The method of claim 1, further comprising:

generating an alert to remind the user to check blood glucose concentration.

12. The method of claim 1, further comprising:

generating feedback representative of the glucose concentration in the blood of the user.

13. A non-invasive blood glucose concentration sensing system, comprising:

a light source configured to emit light of a first color and light of a second color into an eye of a user;

a neurophysiological brain activity sensor configured to sense neurophysiological brain activity of a user and supply neurophysiological brain activity signals representative thereof;

an electroretinography (ERG) sensor configured to sense electrical responses of the eye of the user; and

supply ERG signals representative thereof; and

a processor in operable communication with the light source, the neurophysiological brain activity sensor, and the ERG sensor, the processor coupled to receive the neurophysiological brain activity signals and the ERG signals and configured to;

control the light source to emit the light of the first color and then emit the light of the second color,

process the neurophysiological brain activity signals and the ERG signals, and

correlate one or both of the sensed neurophysiological brain activity and the sensed electrical responses of the eye to the glucose concentration in the blood of the user.

14. The system of claim 13, wherein the processor is configured to control the light source to:

varying intensity of the light of the first color for a predetermined time period to attain a predetermined maximum intensity; and

varying intensity of the light of the second color for the predetermined time period to attain the predetermined maximum intensity.

15. The system of claim 14, further comprising:

a camera configured to take an image of the eye of the user and supply image data thereof to the processor,

wherein the processor is further configured to (i) evaluate the image data to determine retinal health of the eye and (ii) set the predetermined time period and the predetermined maximum intensity based on the retinal health.

16. The system of claim 13, wherein the processor is configured to control the light source to:

emit a pulse of light of the first color at a predetermined intensity and for a predetermined time period; and

emit a pulse of light of the second color at the predetermined intensity and for the predetermined time period

17. The system of claim 16, further comprising:

a camera configured to take an image of the eye of the user and supply image data thereof to the processor,

wherein the processor is further configured to (i) evaluate the image data to determine retinal health of the eye and (ii) set the predetermined time period and the predetermined intensity based on the retinal health.

18. The system of claim 13, wherein the first and second colors are opponent colors.

19. The system of claim 13, wherein the processor is further configured to control the light source to limit retinal pigment bleaching in the eye of the user to a predetermined maximum bleaching percentage.

20. A method for determining glucose concentration in the blood of a user, the method comprising the steps of:

emitting blue light into an eye of the user;

sensing neurophysiological brain activity and electrical responses of the eye of the user during and after emitting the blue light into the eye of the user; and

correlating one or both of the sensed neurophysiological brain activity and the sensed electrical responses of the eye to the glucose concentration in the blood of the user.